About this episode

Rajesh Kumar discusses the rapid evolution of the global healthcare industry, focusing on anti-obesity drugs and the impact of AI.

From the rise of anti-obesity drugs to the impact of AI, Rajesh Kumar, Senior Global Life Sciences & Healthcare Analyst, looks at how the global healthcare industry is evolving at pace. Click here for appropriate Disclosures, including analyst certifications, and Disclaimers that must be viewed with this podcast: https://www.research.hsbc.com/R/101/zWdnMjW Stay connected and access free to view reports and videos from HSBC Global Investment Research follow us on LinkedIn https://www.linkedin.com/feed/hashtag/hsbcresearch/ or click here: https://www.gbm.hsbc.com/insights/global-research

People in this episode

Guest: Rajesh Kumar

Topics covered

• healthcare
• anti-obesity drugs
• AI in healthcare
• global healthcare industry
• life sciences

Keywords

• healthcare
• anti-obesity drugs
• AI
• global healthcare
• life sciences

Mentioned in this episode

Organizations: HSBC, HSBC Global Investment Research, LinkedIn

More episodes of HSBC Global Viewpoint

• The Macro Brief – State of US tariffs · June 5, 2026 · 14 min
• Under the Banyan Tree - China's urbanisation 2.0 · June 5, 2026 · 14 min
• Perspectives: Trust and leadership in the age of AI · June 3, 2026 · 17 min

Explore listener stats, chart rankings, contacts and more on the HSBC Global Viewpoint podcast page.